Peptides of IL1 beta and TNF alpha and method of treatment using same

Details for Australian Patent Application No. 2005220156 (hide)

Owner Vaxconsulting

Inventors Boissier, Marie-Christophe; Bessis, Natacha; Zagury, Jean-Francois

Agent FB Rice

Pub. Number AU-B-2005220156

PCT Pub. Number WO2005/084198

Priority 60/547,848 27.02.04 US

Filing date 25 February 2005

Wipo publication date 15 September 2005

Acceptance publication date 2 June 2011

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084198 Priority application(s): WO2005/084198

2 June 2011 Application Accepted

  Published as AU-B-2005220156

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220159-Direct hinge for optimizing conversion

2005220150-Functional materials and novel methods for the fabrication of microfluidic devices